Seroprevalence of dengue fever among patients attending the health facilities in Kara region in Togo, 2022
Abstract Background The prevalence of dengue fever is variable and is determined by geographical location and individual health status. Anti-dengue antibody seroprevalence also varied according to individual health status. In Togo, data on dengue fever is limited. In this study, we estimated the ser...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-04-01
|
| Series: | Discover Public Health |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12982-025-00540-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850184770250604544 |
|---|---|
| author | Wendpouiré I. C. Zida-Compaore Gatibe Y.-S. Gnatou Sibabé Agoro Roméo Togan Martin K. Tchankoni Fifonsi A. Gbeasor-Komlanvi Didier K. Ekouevi |
| author_facet | Wendpouiré I. C. Zida-Compaore Gatibe Y.-S. Gnatou Sibabé Agoro Roméo Togan Martin K. Tchankoni Fifonsi A. Gbeasor-Komlanvi Didier K. Ekouevi |
| author_sort | Wendpouiré I. C. Zida-Compaore |
| collection | DOAJ |
| description | Abstract Background The prevalence of dengue fever is variable and is determined by geographical location and individual health status. Anti-dengue antibody seroprevalence also varied according to individual health status. In Togo, data on dengue fever is limited. In this study, we estimated the seroprevalence of dengue infections in Kara region in 2022. Methods A cross-sectional study of febrile patients who were visiting the laboratories of health facilities in Kara from March 11 to 30, 2022 was conducted. We collected blood samples from consenting patients. All sera were tested for the presence of dengue AgNS1 and anti-dengue IgM and IgG antibodies. Results Blood samples were collected from 659 patients during the survey. Median age was 26 years (Interquartile range: 18–40 years). The main symptoms that led to consultation were headache, fever, muscle aches and abdominal pain. The overall seroprevalence of dengue virus infection was 17.4% (95% CI [14.7–20.6]). Conclusion This survey strongly suggests that the dengue virus is circulating in the Kara region of northern Togo. Regular surveillance is therefore necessary to inform policy on dengue control and prevention strategies, and consequently to enhance preparedness and response to potential epidemics. |
| format | Article |
| id | doaj-art-bbe794738cb446c19c6658000ece4dcc |
| institution | OA Journals |
| issn | 3005-0774 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Springer |
| record_format | Article |
| series | Discover Public Health |
| spelling | doaj-art-bbe794738cb446c19c6658000ece4dcc2025-08-20T02:16:56ZengSpringerDiscover Public Health3005-07742025-04-012211710.1186/s12982-025-00540-7Seroprevalence of dengue fever among patients attending the health facilities in Kara region in Togo, 2022Wendpouiré I. C. Zida-Compaore0Gatibe Y.-S. Gnatou1Sibabé Agoro2Roméo Togan3Martin K. Tchankoni4Fifonsi A. Gbeasor-Komlanvi5Didier K. Ekouevi6Department of Public Health, Faculty of Health Sciences, University of LoméDepartment of Public Health, Faculty of Health Sciences, University of LoméRegional Health ManagementDepartment of Public Health, Faculty of Health Sciences, University of LoméAfrican Center for Research in Epidemiology and Public HealthDepartment of Public Health, Faculty of Health Sciences, University of LoméDepartment of Public Health, Faculty of Health Sciences, University of LoméAbstract Background The prevalence of dengue fever is variable and is determined by geographical location and individual health status. Anti-dengue antibody seroprevalence also varied according to individual health status. In Togo, data on dengue fever is limited. In this study, we estimated the seroprevalence of dengue infections in Kara region in 2022. Methods A cross-sectional study of febrile patients who were visiting the laboratories of health facilities in Kara from March 11 to 30, 2022 was conducted. We collected blood samples from consenting patients. All sera were tested for the presence of dengue AgNS1 and anti-dengue IgM and IgG antibodies. Results Blood samples were collected from 659 patients during the survey. Median age was 26 years (Interquartile range: 18–40 years). The main symptoms that led to consultation were headache, fever, muscle aches and abdominal pain. The overall seroprevalence of dengue virus infection was 17.4% (95% CI [14.7–20.6]). Conclusion This survey strongly suggests that the dengue virus is circulating in the Kara region of northern Togo. Regular surveillance is therefore necessary to inform policy on dengue control and prevention strategies, and consequently to enhance preparedness and response to potential epidemics.https://doi.org/10.1186/s12982-025-00540-7DengueSeroprevalenceHealth facilitiesKara |
| spellingShingle | Wendpouiré I. C. Zida-Compaore Gatibe Y.-S. Gnatou Sibabé Agoro Roméo Togan Martin K. Tchankoni Fifonsi A. Gbeasor-Komlanvi Didier K. Ekouevi Seroprevalence of dengue fever among patients attending the health facilities in Kara region in Togo, 2022 Discover Public Health Dengue Seroprevalence Health facilities Kara |
| title | Seroprevalence of dengue fever among patients attending the health facilities in Kara region in Togo, 2022 |
| title_full | Seroprevalence of dengue fever among patients attending the health facilities in Kara region in Togo, 2022 |
| title_fullStr | Seroprevalence of dengue fever among patients attending the health facilities in Kara region in Togo, 2022 |
| title_full_unstemmed | Seroprevalence of dengue fever among patients attending the health facilities in Kara region in Togo, 2022 |
| title_short | Seroprevalence of dengue fever among patients attending the health facilities in Kara region in Togo, 2022 |
| title_sort | seroprevalence of dengue fever among patients attending the health facilities in kara region in togo 2022 |
| topic | Dengue Seroprevalence Health facilities Kara |
| url | https://doi.org/10.1186/s12982-025-00540-7 |
| work_keys_str_mv | AT wendpouireiczidacompaore seroprevalenceofdenguefeveramongpatientsattendingthehealthfacilitiesinkararegionintogo2022 AT gatibeysgnatou seroprevalenceofdenguefeveramongpatientsattendingthehealthfacilitiesinkararegionintogo2022 AT sibabeagoro seroprevalenceofdenguefeveramongpatientsattendingthehealthfacilitiesinkararegionintogo2022 AT romeotogan seroprevalenceofdenguefeveramongpatientsattendingthehealthfacilitiesinkararegionintogo2022 AT martinktchankoni seroprevalenceofdenguefeveramongpatientsattendingthehealthfacilitiesinkararegionintogo2022 AT fifonsiagbeasorkomlanvi seroprevalenceofdenguefeveramongpatientsattendingthehealthfacilitiesinkararegionintogo2022 AT didierkekouevi seroprevalenceofdenguefeveramongpatientsattendingthehealthfacilitiesinkararegionintogo2022 |